by Marco Torres, Prevent Disease, Waking Times
There are close to 20,000 studies on cannabinoids in the pubmed database. Few scientists who concentrate their work around cannabinoids can deny the tremendous therapeutic potential of cannabis. Dr. Christina Sanchez, a molecular biologist at Compultense University in Madrid Spain, has completed extensive research which led to one of the first discoveries that THC does indeed kill cancer cells.
The endocannabinoid system is a group of receptors in the brain that are involved in a variety of physiological processes including appetite, pain-sensation, mood, and memory; it mediates many physiological processes, including motor learning, synaptic plasticity, and appetite.
The Endocannabinoid System (ECS) maintains our biological systems by regulating each cell tissue. It uses Arachadonic acid/Omega 6 to make Endo-Cannabinoids: fatty molecules that communicate harm between cells. Dietary Cannabis mimics the ECS by providing Cannabinoids when there is an Arachadonic acid deficiency or Clinical Cannabinoid Deficiency.
The discovery in the early 1990s of specific membrane receptors of marijuana’s psychoactive component 9-tetrahydrocannabinol (THC) opened the way to the revelation of a whole endogenous signaling system which is the endocannabinoid system.
One of the most incredible findings of the endocannabinoid system it that it appears to be conserved at least in all vertebrate phyla, and present in the structure of receptors and in their function, also in invertebrates, thus implying its participation in vital functions in almost all organisms.